Antenatal Bartter's syndrome: why is this not a lethal condition?

There are four themes in this teaching exercise for Professor McCance. The first challenge was to explain how a premature infant with Bartter's syndrome could survive despite having such a severe degree of renal salt wasting. Second, the medical team wanted to know why there was such a dramatic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:QJM : An International Journal of Medicine 2008-12, Vol.101 (12), p.927-942
Hauptverfasser: Bockenhauer, D., Cruwys, M., Kleta, R., Halperin, L.F., Wildgoose, P., Souma, T., Nukiwa, N., Cheema-Dhadli, S., Chong, C.K., Kamel, K.S., Davids, M.R., Halperin, M.L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 942
container_issue 12
container_start_page 927
container_title QJM : An International Journal of Medicine
container_volume 101
creator Bockenhauer, D.
Cruwys, M.
Kleta, R.
Halperin, L.F.
Wildgoose, P.
Souma, T.
Nukiwa, N.
Cheema-Dhadli, S.
Chong, C.K.
Kamel, K.S.
Davids, M.R.
Halperin, M.L.
description There are four themes in this teaching exercise for Professor McCance. The first challenge was to explain how a premature infant with Bartter's syndrome could survive despite having such a severe degree of renal salt wasting. Second, the medical team wanted to know why there was such a dramatic decrease in the natriuresis in response to therapy, despite the presence of a permanent molecular defect that affected the loop of Henle. Third, Professor McCance was asked why this patient seemed to have a second rare disease, AQP2 deficiency type of nephrogenic diabetes insipidus. The fourth challenge was to develop a diagnostic test to help the parents of this baby titrate the dose of indomethacin to ensure an effective dose while minimizing the likelihood of developing nephrotoxicity. The missing links in this interesting story emerge during a discussion between the medical team and its mentor.
doi_str_mv 10.1093/qjmed/hcn119
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_229550018</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/qjmed/hcn119</oup_id><sourcerecordid>1602905851</sourcerecordid><originalsourceid>FETCH-LOGICAL-c454t-f02a8b80004e6075f0d21382472c3c38fadda479d43293021161d30c8226ddf93</originalsourceid><addsrcrecordid>eNqF0MFLwzAUBvAgitPpzbMUQXaxLi9p2tSLzKFOGXpQQbyELElZ55ZuSYbuv7ezc1cvSQg_3vf4EDoBfAk4p93FZGZ0d6wsQL6DDiBJcUxoTnf_3hlhLXTo_QRjnGQJ30ct4JzkGdAD1OvZYKwMchrdSBeCcR0f-ZXVrpqZq-hrvIpKH4VxfdgqRDKamjCusaqsLkNZ2esjtFfIqTfHm7uN3u5uX_uDePh8_9DvDWOVsCTEBSaSj_h6B5PijBVYE6CcJBlRVFFeSK1lkuU6oSSnmACkoClWnJBU6yKnbXTWzJ27arE0PohJtXS2jhSE5IxhDLxGFw1SrvLemULMXTmTbiUAi3Vd4rcu0dRV89PNzOVo_b3Fm35qcL4B0is5LZy0qvRbR3AdDAxq12lctZz_Fxk3svTBfG-tdJ8izWjGxOD9Qzyxl8cUgAlKfwDM7I4r</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229550018</pqid></control><display><type>article</type><title>Antenatal Bartter's syndrome: why is this not a lethal condition?</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Bockenhauer, D. ; Cruwys, M. ; Kleta, R. ; Halperin, L.F. ; Wildgoose, P. ; Souma, T. ; Nukiwa, N. ; Cheema-Dhadli, S. ; Chong, C.K. ; Kamel, K.S. ; Davids, M.R. ; Halperin, M.L.</creator><creatorcontrib>Bockenhauer, D. ; Cruwys, M. ; Kleta, R. ; Halperin, L.F. ; Wildgoose, P. ; Souma, T. ; Nukiwa, N. ; Cheema-Dhadli, S. ; Chong, C.K. ; Kamel, K.S. ; Davids, M.R. ; Halperin, M.L.</creatorcontrib><description>There are four themes in this teaching exercise for Professor McCance. The first challenge was to explain how a premature infant with Bartter's syndrome could survive despite having such a severe degree of renal salt wasting. Second, the medical team wanted to know why there was such a dramatic decrease in the natriuresis in response to therapy, despite the presence of a permanent molecular defect that affected the loop of Henle. Third, Professor McCance was asked why this patient seemed to have a second rare disease, AQP2 deficiency type of nephrogenic diabetes insipidus. The fourth challenge was to develop a diagnostic test to help the parents of this baby titrate the dose of indomethacin to ensure an effective dose while minimizing the likelihood of developing nephrotoxicity. The missing links in this interesting story emerge during a discussion between the medical team and its mentor.</description><identifier>ISSN: 1460-2725</identifier><identifier>EISSN: 1460-2393</identifier><identifier>DOI: 10.1093/qjmed/hcn119</identifier><identifier>PMID: 18829713</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Animals ; Aquaporin 1 - deficiency ; Bartter Syndrome - complications ; Bartter Syndrome - congenital ; Bartter Syndrome - therapy ; Biological and medical sciences ; Chlorides - urine ; Diabetes Insipidus, Nephrogenic - diagnosis ; Diabetes Insipidus, Nephrogenic - drug therapy ; General aspects ; Glomerulonephritis ; Humans ; Hyperaldosteronism - etiology ; Indomethacin - administration &amp; dosage ; Infant ; Infant, Newborn ; Infant, Premature ; Kidney Diseases - diagnosis ; Kidney Diseases - physiopathology ; Loop of Henle - physiology ; Male ; Medical sciences ; Nephrology. Urinary tract diseases ; Nephropathies. Renovascular diseases. Renal failure ; Rats ; Sodium - metabolism ; Sodium - urine</subject><ispartof>QJM : An International Journal of Medicine, 2008-12, Vol.101 (12), p.927-942</ispartof><rights>The Author 2008. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org 2008</rights><rights>2009 INIST-CNRS</rights><rights>The Author 2008. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c454t-f02a8b80004e6075f0d21382472c3c38fadda479d43293021161d30c8226ddf93</citedby><cites>FETCH-LOGICAL-c454t-f02a8b80004e6075f0d21382472c3c38fadda479d43293021161d30c8226ddf93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,1585,27929,27930</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20955151$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18829713$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bockenhauer, D.</creatorcontrib><creatorcontrib>Cruwys, M.</creatorcontrib><creatorcontrib>Kleta, R.</creatorcontrib><creatorcontrib>Halperin, L.F.</creatorcontrib><creatorcontrib>Wildgoose, P.</creatorcontrib><creatorcontrib>Souma, T.</creatorcontrib><creatorcontrib>Nukiwa, N.</creatorcontrib><creatorcontrib>Cheema-Dhadli, S.</creatorcontrib><creatorcontrib>Chong, C.K.</creatorcontrib><creatorcontrib>Kamel, K.S.</creatorcontrib><creatorcontrib>Davids, M.R.</creatorcontrib><creatorcontrib>Halperin, M.L.</creatorcontrib><title>Antenatal Bartter's syndrome: why is this not a lethal condition?</title><title>QJM : An International Journal of Medicine</title><addtitle>QJM</addtitle><description>There are four themes in this teaching exercise for Professor McCance. The first challenge was to explain how a premature infant with Bartter's syndrome could survive despite having such a severe degree of renal salt wasting. Second, the medical team wanted to know why there was such a dramatic decrease in the natriuresis in response to therapy, despite the presence of a permanent molecular defect that affected the loop of Henle. Third, Professor McCance was asked why this patient seemed to have a second rare disease, AQP2 deficiency type of nephrogenic diabetes insipidus. The fourth challenge was to develop a diagnostic test to help the parents of this baby titrate the dose of indomethacin to ensure an effective dose while minimizing the likelihood of developing nephrotoxicity. The missing links in this interesting story emerge during a discussion between the medical team and its mentor.</description><subject>Animals</subject><subject>Aquaporin 1 - deficiency</subject><subject>Bartter Syndrome - complications</subject><subject>Bartter Syndrome - congenital</subject><subject>Bartter Syndrome - therapy</subject><subject>Biological and medical sciences</subject><subject>Chlorides - urine</subject><subject>Diabetes Insipidus, Nephrogenic - diagnosis</subject><subject>Diabetes Insipidus, Nephrogenic - drug therapy</subject><subject>General aspects</subject><subject>Glomerulonephritis</subject><subject>Humans</subject><subject>Hyperaldosteronism - etiology</subject><subject>Indomethacin - administration &amp; dosage</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infant, Premature</subject><subject>Kidney Diseases - diagnosis</subject><subject>Kidney Diseases - physiopathology</subject><subject>Loop of Henle - physiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Nephropathies. Renovascular diseases. Renal failure</subject><subject>Rats</subject><subject>Sodium - metabolism</subject><subject>Sodium - urine</subject><issn>1460-2725</issn><issn>1460-2393</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0MFLwzAUBvAgitPpzbMUQXaxLi9p2tSLzKFOGXpQQbyELElZ55ZuSYbuv7ezc1cvSQg_3vf4EDoBfAk4p93FZGZ0d6wsQL6DDiBJcUxoTnf_3hlhLXTo_QRjnGQJ30ct4JzkGdAD1OvZYKwMchrdSBeCcR0f-ZXVrpqZq-hrvIpKH4VxfdgqRDKamjCusaqsLkNZ2esjtFfIqTfHm7uN3u5uX_uDePh8_9DvDWOVsCTEBSaSj_h6B5PijBVYE6CcJBlRVFFeSK1lkuU6oSSnmACkoClWnJBU6yKnbXTWzJ27arE0PohJtXS2jhSE5IxhDLxGFw1SrvLemULMXTmTbiUAi3Vd4rcu0dRV89PNzOVo_b3Fm35qcL4B0is5LZy0qvRbR3AdDAxq12lctZz_Fxk3svTBfG-tdJ8izWjGxOD9Qzyxl8cUgAlKfwDM7I4r</recordid><startdate>20081201</startdate><enddate>20081201</enddate><creator>Bockenhauer, D.</creator><creator>Cruwys, M.</creator><creator>Kleta, R.</creator><creator>Halperin, L.F.</creator><creator>Wildgoose, P.</creator><creator>Souma, T.</creator><creator>Nukiwa, N.</creator><creator>Cheema-Dhadli, S.</creator><creator>Chong, C.K.</creator><creator>Kamel, K.S.</creator><creator>Davids, M.R.</creator><creator>Halperin, M.L.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope></search><sort><creationdate>20081201</creationdate><title>Antenatal Bartter's syndrome: why is this not a lethal condition?</title><author>Bockenhauer, D. ; Cruwys, M. ; Kleta, R. ; Halperin, L.F. ; Wildgoose, P. ; Souma, T. ; Nukiwa, N. ; Cheema-Dhadli, S. ; Chong, C.K. ; Kamel, K.S. ; Davids, M.R. ; Halperin, M.L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c454t-f02a8b80004e6075f0d21382472c3c38fadda479d43293021161d30c8226ddf93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Aquaporin 1 - deficiency</topic><topic>Bartter Syndrome - complications</topic><topic>Bartter Syndrome - congenital</topic><topic>Bartter Syndrome - therapy</topic><topic>Biological and medical sciences</topic><topic>Chlorides - urine</topic><topic>Diabetes Insipidus, Nephrogenic - diagnosis</topic><topic>Diabetes Insipidus, Nephrogenic - drug therapy</topic><topic>General aspects</topic><topic>Glomerulonephritis</topic><topic>Humans</topic><topic>Hyperaldosteronism - etiology</topic><topic>Indomethacin - administration &amp; dosage</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infant, Premature</topic><topic>Kidney Diseases - diagnosis</topic><topic>Kidney Diseases - physiopathology</topic><topic>Loop of Henle - physiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Nephropathies. Renovascular diseases. Renal failure</topic><topic>Rats</topic><topic>Sodium - metabolism</topic><topic>Sodium - urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bockenhauer, D.</creatorcontrib><creatorcontrib>Cruwys, M.</creatorcontrib><creatorcontrib>Kleta, R.</creatorcontrib><creatorcontrib>Halperin, L.F.</creatorcontrib><creatorcontrib>Wildgoose, P.</creatorcontrib><creatorcontrib>Souma, T.</creatorcontrib><creatorcontrib>Nukiwa, N.</creatorcontrib><creatorcontrib>Cheema-Dhadli, S.</creatorcontrib><creatorcontrib>Chong, C.K.</creatorcontrib><creatorcontrib>Kamel, K.S.</creatorcontrib><creatorcontrib>Davids, M.R.</creatorcontrib><creatorcontrib>Halperin, M.L.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>QJM : An International Journal of Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bockenhauer, D.</au><au>Cruwys, M.</au><au>Kleta, R.</au><au>Halperin, L.F.</au><au>Wildgoose, P.</au><au>Souma, T.</au><au>Nukiwa, N.</au><au>Cheema-Dhadli, S.</au><au>Chong, C.K.</au><au>Kamel, K.S.</au><au>Davids, M.R.</au><au>Halperin, M.L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antenatal Bartter's syndrome: why is this not a lethal condition?</atitle><jtitle>QJM : An International Journal of Medicine</jtitle><addtitle>QJM</addtitle><date>2008-12-01</date><risdate>2008</risdate><volume>101</volume><issue>12</issue><spage>927</spage><epage>942</epage><pages>927-942</pages><issn>1460-2725</issn><eissn>1460-2393</eissn><abstract>There are four themes in this teaching exercise for Professor McCance. The first challenge was to explain how a premature infant with Bartter's syndrome could survive despite having such a severe degree of renal salt wasting. Second, the medical team wanted to know why there was such a dramatic decrease in the natriuresis in response to therapy, despite the presence of a permanent molecular defect that affected the loop of Henle. Third, Professor McCance was asked why this patient seemed to have a second rare disease, AQP2 deficiency type of nephrogenic diabetes insipidus. The fourth challenge was to develop a diagnostic test to help the parents of this baby titrate the dose of indomethacin to ensure an effective dose while minimizing the likelihood of developing nephrotoxicity. The missing links in this interesting story emerge during a discussion between the medical team and its mentor.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>18829713</pmid><doi>10.1093/qjmed/hcn119</doi><tpages>16</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1460-2725
ispartof QJM : An International Journal of Medicine, 2008-12, Vol.101 (12), p.927-942
issn 1460-2725
1460-2393
language eng
recordid cdi_proquest_journals_229550018
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Animals
Aquaporin 1 - deficiency
Bartter Syndrome - complications
Bartter Syndrome - congenital
Bartter Syndrome - therapy
Biological and medical sciences
Chlorides - urine
Diabetes Insipidus, Nephrogenic - diagnosis
Diabetes Insipidus, Nephrogenic - drug therapy
General aspects
Glomerulonephritis
Humans
Hyperaldosteronism - etiology
Indomethacin - administration & dosage
Infant
Infant, Newborn
Infant, Premature
Kidney Diseases - diagnosis
Kidney Diseases - physiopathology
Loop of Henle - physiology
Male
Medical sciences
Nephrology. Urinary tract diseases
Nephropathies. Renovascular diseases. Renal failure
Rats
Sodium - metabolism
Sodium - urine
title Antenatal Bartter's syndrome: why is this not a lethal condition?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T09%3A21%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antenatal%20Bartter's%20syndrome:%20why%20is%20this%20not%20a%20lethal%20condition?&rft.jtitle=QJM%20:%20An%20International%20Journal%20of%20Medicine&rft.au=Bockenhauer,%20D.&rft.date=2008-12-01&rft.volume=101&rft.issue=12&rft.spage=927&rft.epage=942&rft.pages=927-942&rft.issn=1460-2725&rft.eissn=1460-2393&rft_id=info:doi/10.1093/qjmed/hcn119&rft_dat=%3Cproquest_cross%3E1602905851%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=229550018&rft_id=info:pmid/18829713&rft_oup_id=10.1093/qjmed/hcn119&rfr_iscdi=true